Euro Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 6.10 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 1.00 Cr
About Euro Formulations
Euro Formulations Private Limited (EFPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 May 2010 and has a history of 14 years and eight months. Its registered office is in Bhind, Madhya Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Netrapal Singh and Sanjay Pathak serve as directors at the Company.
Company Details
- Location
Bhind, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232MP2010PTC023679
- Company No.
023679
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2010
- Date of AGM
29 Jul 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Euro Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Netrapal Singh  | Director | 14-May-2015 | Current |
| Sanjay Pathak | Additional Director | 01-May-2018 | Current |
Financial Performance of Euro Formulations.
Enhance accessibility to Euro Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Euro Formulations?
In 2016, Euro Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Seven Triangle Supply Chain LlpNetrapal Singh is a mutual person
- Eurofarm Organics Private Limited
Netrapal Singh is a mutual person
- Firsttrack Roadlines Private Limited
Sanjay Pathak is a mutual person
- Kritika Life Sciences Private Limited
Sanjay Pathak is a mutual person
Charges (Loans)
₹1.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2016 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Euro Formulations?
Unlock and access historical data on people associated with Euro Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Euro Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euro Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
